FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, in particular, provided are methods for identifying single-nucleotide variants in lung cancer, in particular, in stage 3a lung adenocarcinoma and squamous cell lung carcinoma. Provided are additional methods and compositions, such as reaction mixtures and solid substrates containing clonal populations of nucleic acids.
EFFECT: identification of single-nucleotide variants in lung cancer.
39 cl, 21 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHODS OF DETECTING AND MONITORING CANCER BY PERSONALIZED DETECTION OF CIRCULATING TUMOR DNA | 2019 |
|
RU2811503C2 |
DETECTION OF MUTATIONS AND PLOIDY IN CHROMOSOMAL SEGMENTS | 2015 |
|
RU2717641C2 |
HIGHLY MULTIPLEX PCR METHODS AND COMPOSITIONS | 2012 |
|
RU2650790C2 |
METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING | 2011 |
|
RU2671980C2 |
METHODS FOR DNA AMPLIFICATION TO PRESERVE METHYLATION STATUS | 2018 |
|
RU2754038C2 |
METHODS OF NONINVASIVE PRENATAL PATERNITY DETERMINATION | 2011 |
|
RU2620959C2 |
METHODS AND COMPOSITIONS FOR DNA PROFILING | 2015 |
|
RU2708337C2 |
BIOMARKER PANEL AND METHODS FOR DETECTING MICROSATELLITE INSTABILITY IN VARIOUS TYPES OF CANCER | 2019 |
|
RU2795410C2 |
POLYNUCLEOTIDE PRIMERS | 2008 |
|
RU2491289C2 |
DIRECT CAPTURE, AMPLIFICATION AND SEQUENCING OF TARGET DNA USING IMMOBILISED PRIMERS | 2011 |
|
RU2565550C2 |
Authors
Dates
2021-12-01—Published
2017-04-17—Filed